FDA Drug Topics: Biosimilar and Interchangeable Products in the U.S.: Scientific Concepts, Clinical Use, and Practical Considerations – December 10, 2018
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On Monday, December 10, 2018, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Drug Topics: Biosimilar and Interchangeable Products in the U.S.: Scientific Concepts, Clinical Use, and Practical Considerations. This webinar provided an overview of biosimilar and interchangeable products and the approval process in the U.S. This webinar also explained the various scientific concepts used in the development of biosimilar products and the FDA's approval standards. In addition, we described some practical information regarding use of these products, such as labeling, terminology, and pharmacy substitution and reviewed the resources available to health care professionals about biosimilar and interchangeable products.
View Presentation Here: https://collaboration.fda.gov/p722nxwu6hjq/
Download Presentation Slides: Biosimilar and Interchangeable Products in the U.S. (PDF - 729KB)
Activity Outline and Continuing Education Information: Biosimilar and Interchangeable Products in the U.S. (PDF - 170KB)
If you have never attended an Adobe Connect meeting before:
Test your connection: Adobe Connect Diagnostic Test
Get a quick overview: Discover Adobe Connect Solutions
Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.